Cargando…
Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer
Somatic mutations in the gene encoding epidermal growth factor receptor (EGFR) play an important role in determining targeted treatment modalities in non-small cell lung cancer (NSCLC). The EGFR T790M mutation emerges in approximately 50% of cases who acquire resistance to tyrosine kinase inhibitors...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725066/ https://www.ncbi.nlm.nih.gov/pubmed/29246024 http://dx.doi.org/10.18632/oncotarget.19007 |